Literature DB >> 23332616

Ontogeny and localization of the cells produce IL-2 in healthy animals.

Mutsumi Yamamoto1, Yoichi Seki, Kazuyuki Iwai, Iei Ko, Alicia Martin, Noriko Tsuji, Shuji Miyagawa, Robert B Love, Makio Iwashima.   

Abstract

IL-2 is a growth factor for activated T cells and is required for maintenance of naturally arising regulatory T cells (nTregs). Mice defective in IL-2/IL-2 receptor signaling pathways have impaired nTregs and suffer from lymphoproliferative disorders, suggesting that IL-2 is present and functional in healthy animals. However, the cellular source of IL-2 is currently unknown. To determine which cells produce IL-2 in healthy animals, we established mice carrying cre gene knock in at the il-2 locus (termed IL-2(cre)). When IL-2(cre) mice were crossed with EGFP reporter mice, EGFP was exclusively expressed by a fraction of CD4 T cells present in both lymphoid and non-lymphoid tissues. Live imaging of IL-2(cre) mice that carry the luciferase reporter showed concentrated localization of luciferase(+) cells in Peyer's patches. These cells were not observed in new born mice but appeared within 3days after birth. Reduction of antigen receptor repertoire by transgene expression reduced their number, indicating that recognition of environmental antigens is necessary for generation of these IL-2 producers in healthy animals. A substantial fraction of EGFP(+) cells also produce IL-10 and IFN-γ, a characteristic profile of type 1 regulatory T cells (Tr1). The data suggest that a group of Tr1 cells have addition roles in immune homeostasis by producing IL-2 along with other cytokines and help maintaining Tregs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332616      PMCID: PMC3595346          DOI: 10.1016/j.cyto.2012.11.026

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

1.  Interactions between commensal intestinal bacteria and the immune system.

Authors:  Andrew J Macpherson; Nicola L Harris
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

2.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

Review 3.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

Review 4.  Interleukin-2 tickles T cell memory.

Authors:  Gabrielle T Belz; Frédérick Masson
Journal:  Immunity       Date:  2010-01-29       Impact factor: 31.745

Review 5.  Kinetic perspectives of T cell antigen receptor signaling. A two-tier model for T cell full activation.

Authors:  Makio Iwashima
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

6.  A new regulatory region of the IL-2 locus that confers position-independent transgene expression.

Authors:  M A Yui; G Hernández-Hoyos; E V Rothenberg
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

7.  Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination.

Authors:  Michal Safran; William Y Kim; Andrew L Kung; James W Horner; Ron A DePinho; William G Kaelin
Journal:  Mol Imaging       Date:  2003-10       Impact factor: 4.488

Review 8.  Advances in understanding the anti-inflammatory properties of IL-27.

Authors:  J S Stumhofer; C A Hunter
Journal:  Immunol Lett       Date:  2008-03-03       Impact factor: 3.685

9.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.

Authors:  Silvia Gregori; Kevin S Goudy; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2012-02-29       Impact factor: 7.561

View more
  6 in total

1.  Activated human Foxp3+ regulatory T cells produce membrane-bound TNF.

Authors:  Alexander Nelson; Christina Cunha; Michael I Nishimura; Makio Iwashima
Journal:  Cytokine       Date:  2018-06-06       Impact factor: 3.861

2.  Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate decisions, stemness, and protection.

Authors:  Shannon M Kahan; Rakesh K Bakshi; Jennifer T Ingram; R Curtis Hendrickson; Elliot J Lefkowitz; David K Crossman; Laurie E Harrington; Casey T Weaver; Allan J Zajac
Journal:  Sci Immunol       Date:  2022-02-11

3.  Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.

Authors:  Carly E Whyte; Kailash Singh; James Dooley; Oliver T Burton; Meryem Aloulou; Lubna Kouser; Rafael Valente Veiga; Amy Dashwood; Hanneke Okkenhaug; Samira Benadda; Alena Moudra; Orian Bricard; Stephanie Lienart; Pascal Bielefeld; Carlos P Roca; Francisco José Naranjo-Galindo; Félix Lombard-Vadnais; Steffie Junius; David Bending; Masahiro Ono; Tino Hochepied; Timotheus Y F Halim; Susan Schlenner; Sylvie Lesage; Adrian Liston
Journal:  J Exp Med       Date:  2022-06-14       Impact factor: 17.579

Review 4.  Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act.

Authors:  Vandana Kalia; Surojit Sarkar
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

5.  IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus.

Authors:  Saskia Hemmers; Michail Schizas; Elham Azizi; Stanislav Dikiy; Yi Zhong; Yongqiang Feng; Grégoire Altan-Bonnet; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2019-08-21       Impact factor: 14.307

6.  Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity.

Authors:  Chloe J Pyle; Lucia Labeur-Iurman; Helen T Groves; Franz Puttur; Clare M Lloyd; John S Tregoning; James A Harker
Journal:  J Exp Med       Date:  2021-10-19       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.